Ovarian cancer risk associated with inherited inflammation-related variants.
暂无分享,去创建一个
Brooke L. Fridley | Michael J. Birrer | Honglin Song | Susan J. Ramus | Simon A. Gayther | Rebecca Sutphen | Catherine M. Phelan | Montserrat Garcia-Closas | Nicolas Wentzensen | Edwin S. Iversen | David N. Rider | Thomas A. Sellers | Ellen L. Goode | R. Vierkant | T. Sellers | M. García-Closas | B. Fridley | Kristin L. White | E. Goode | A. Berchuck | E. Iversen | J. Cunningham | P. Pharoah | J. Tyrer | S. Gayther | M. Birrer | N. Wentzensen | R. Sutphen | J. Schildkraut | M. Cicek | Hannah P. Yang | D. N. Rider | Honglin Song | C. Phelan | S. Ramus | Rachel T. Palmieri | Bridget Charbonneau | Andrew Berchuck | Jonathan Tyrer | Joellen M. Schildkraut | Robert A. Vierkant | Bridget Charbonneau | Mine S. Cicek | Paul P. D. Pharoah | Julie M. Cunningham
[1] Sebastian M. Armasu,et al. Inherited Determinants of Ovarian Cancer Survival , 2010, Clinical Cancer Research.
[2] L. Wilkens,et al. Pooled analysis of the association of PTGS2 rs5275 polymorphism and NSAID use with invasive ovarian carcinoma risk , 2010, Cancer Causes & Control.
[3] D. Parkin,et al. Global cancer statistics in the year 2000. , 2001, The Lancet. Oncology.
[4] M. Hauptmann,et al. Polymorphisms in Apoptosis- and Proliferation-Related Genes, Ionizing Radiation Exposure, and Risk of Breast Cancer among U.S. Radiologic Technologists , 2007, Cancer Epidemiology Biomarkers & Prevention.
[5] A. Whittemore,et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer , 2010, Nature Genetics.
[6] D. Cramer,et al. Epidemiologic perspective on immune-surveillance in cancer. , 2011, Current opinion in immunology.
[7] R. Vierkant,et al. LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. , 2011, Cancer research.
[8] P. Deininger,et al. Applications of computational algorithm tools to identify functional SNPs in cytokine genes. , 2006, Cytokine.
[9] J Tuomilehto,et al. Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis , 2007, Annals of the rheumatic diseases.
[10] W. Han,et al. Multiplex genotyping of 1107 SNPs from 232 candidate genes identified an association between IL1A polymorphism and breast cancer risk. , 2010, Oncology reports.
[11] P. Taylor,et al. J Soc Gynecol Investig , 2005 .
[12] A. Jemal,et al. Global Cancer Statistics , 2011 .
[13] P. Allavena,et al. Cancer-related inflammation , 2008, Nature.
[14] Sonja J. Prohaska,et al. “Genes” , 2008, Theory in Biosciences.
[15] Ronald D. Alvarez,et al. Lipoxygenase Pathway Receptor Expression in Ovarian Cancer , 2008, Reproductive Sciences.
[16] R. Zeillinger,et al. Polymorphisms of the interleukin-1 gene cluster and ovarian cancer. , 2002, Journal of the Society for Gynecologic Investigation.
[17] Nathaniel Rothman,et al. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. , 2004, Journal of the National Cancer Institute.
[18] M. Sughrue,et al. Cancer and the Complement Cascade , 2010, Molecular Cancer Research.
[19] M. Karin,et al. Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage , 2011, Annals of the rheumatic diseases.
[20] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[21] A. Whittemore,et al. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24 , 2010, Nature Genetics.
[22] A. Whittemore,et al. Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer , 2007, Human mutation.
[23] R. Vierkant,et al. Polymorphisms in NF-κB Inhibitors and Risk of Epithelial Ovarian Cancer , 2009, BMC Cancer.